Showing results (21-30 of 128) with videos related to
Sort By:
Pageof 13
Current Pharmaceutical Design|November 30, 2007
Valproic acid as anti-cancer drugMartin Michaelis, Hans Wilhelm Doerr, Jindrich CinatlTrends in Microbiology|April 23, 2003
Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistenceMartin Scholz, Hans Wilhelm Doerr, Jindrich CinatlCurrent Molecular Medicine|March 12, 2009
Of chickens and men: avian influenza in humansMartin Michaelis, Hans Wilhelm Doerr, Jindrich CinatlMedical Microbiology and Immunology|November 27, 2009
Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in GermanyHolger F Rabenau, Matthias Richter, Hans Wilhelm DoerrExpert Opinion on Biological Therapy|June 4, 2004
Role of interferons in the treatment of severe acute respiratory syndromeJindrich Cinatl, Martin Michaelis, Martin Scholz, et al.Journal of Clinical Microbiology|March 30, 2002
Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO UltraBernard Weber, Annemarie Berger, Holger Rabenau, et al.Medical Microbiology and Immunology|December 2, 2009
Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed?Paul R Lübeck, Hans Wilhelm Doerr, Holger F RabenauExpert Review of Molecular Diagnostics|May 11, 2007
Molecular assays for monitoring HIV infection and antiretroviral therapyMiriam Wittek, Martin Stürmer, Hans Wilhelm Doerr, et al.Antiviral Therapy|August 20, 2003
Comparison of nine resistance interpretation systems for HIV-1 genotypingMartin Stürmer, Hans Wilhelm Doerr, Schlomo Staszewski, et al.International Journal of Molecular Medicine|January 14, 2005
High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cellsJindrich Cinatl, Martin Michaelis, Birgit Morgenstern, et al.Pageof 13